lfs ethephon + mepiquat-chlorid flydende middel
lfs kemi - ethephon, mepiquat-chlorid, mepiquat - flydende middel - 155 g/l ethephon ; 305 g/l mepiquat-chlorid ; (~ 233 g/l mepiquat
lfs metconazol/mepiquat-chlorid vandopløseligt koncentrat
lfs kemi - metconazol, mepiquat-chlorid, mepiquat - vandopløseligt koncentrat - 30 g/l metconazol ; 210 g/l mepiquat-chlorid ; (~ 160 g/l mepiquat
medax top suspensionskoncentrat
basf a/s - mepiquat-chlorid, mepiquat, prohexadion-calcium, prohexadion - suspensionskoncentrat - 300 g/l mepiquat-chlorid ; (~ 229 g/l mepiquat) ; 50 g/l prohexadion-calcium ; (~ 42,4 g/l prohexadion)
terpal vandopløseligt koncentrat
basf a/s - ethephon, mepiquat-chlorid, mepiquat - vandopløseligt koncentrat - 155 g/l ethephon ; 305 g/l mepiquat-chlorid ; (~ 233 g/l mepiquat)
caryx vandopløseligt koncentrat
basf a/s - metconazol, mepiquat-chlorid, mepiquat - vandopløseligt koncentrat - 30 g/l metconazol ; 210 g/l mepiquat-chlorid ; (~ 160 g/l mepiquat)
inter-short flydende middel
inter-trade a/s - ethephon, mepiquat-chlorid, mepiquat - flydende middel - 155 g/l ethephon ; 305 g/l mepiquat-chlorid ; (~ 233 g/l mepiquat
terpal c flydende middel
basf a/s - ethephon, chlormequat-chlorid, chlormequat - flydende middel - 155 g/l ethephon ; 305 g/l chlormequat-chlorid ; (~ 237 g/l chlormequat
it-diquat vandopløseligt koncentrat
upl europe ltd. (tidligere: united phosphorus ltd.) - diquat, diquat - vandopløseligt koncentrat - 374 g/l diquat dibromid ; (~ 200 g/l diquat
inter-diquat vandopløseligt koncentrat
inter-trade a/s - diquat, diquat - vandopløseligt koncentrat - 374 g/l diquat dibromid ; (~ 200 g/l diquat
sitagliptin / metformin hydrochloride sun
sun pharmaceutical industries europe b.v. - sitagliptin fumarate, metformin hydrochloride - diabetes mellitus, type 2 - narkotika anvendt i diabetes - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride sun is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride sun is indicated in combination with a sulphonylurea (i. - , trepersoners-kombinationsbehandling) som supplement til diæt og motion hos patienter, der ikke er tilstrækkeligt kontrolleret på deres maksimal tolereret dosis af metformin og et sulphonylurea. sitagliptin/metformin hydrochloride sun is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. sitagliptin/metformin hydrochloride sun is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.